tiprankstipranks
Advertisement
Advertisement

DXR Stock Latest News

Daxor to showcase next-gen portable BVA at ACC.26 session
The FlyDaxor to showcase next-gen portable BVA at ACC.26 session
2M ago
DXR
Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress
PremiumThe Fly
Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress
2M ago
DXR
Daxor issues update in Letter to Shareholders
PremiumThe Fly
Daxor issues update in Letter to Shareholders
2M ago
DXR
Daxor reports NAV per share of $9.07
PremiumThe Fly
Daxor reports NAV per share of $9.07
2M ago
DXR
Daxor continues strategic expansion, opens new BVA program in Tennessee
PremiumThe Fly
Daxor continues strategic expansion, opens new BVA program in Tennessee
3M ago
DXR
Daxor initiated with a Buy at Lake Street
PremiumThe FlyDaxor initiated with a Buy at Lake Street
3M ago
DXR
Daxor to transition to Securities Exchange Act of 1934 reporting company
Premium
The Fly
Daxor to transition to Securities Exchange Act of 1934 reporting company
3M ago
DXR
Daxor Files Legal Opinion Affirming Validity of Stock
Premium
Company Announcements
Daxor Files Legal Opinion Affirming Validity of Stock
4M ago
8K
DXR
Daxor prices 765,958 shares at $11.75 in registered direct offering
PremiumThe Fly
Daxor prices 765,958 shares at $11.75 in registered direct offering
4M ago
DXR
Daxor Releases Updated Investor Presentation to Public Markets
PremiumCompany Announcements
Daxor Releases Updated Investor Presentation to Public Markets
4M ago
8K
DXR
Daxor announces expansion of its BVA platform into three new facilities
PremiumThe Fly
Daxor announces expansion of its BVA platform into three new facilities
6M ago
DXR
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference
PremiumThe Fly
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference
7M ago
DXR
Daxor debuts FDA-cleared BVA analyzer at HFSA meeting
PremiumThe FlyDaxor debuts FDA-cleared BVA analyzer at HFSA meeting
8M ago
DXR
Daxor unveils next-gen BVA analyzer at HFSA annual meeting
Premium
The Fly
Daxor unveils next-gen BVA analyzer at HFSA annual meeting
8M ago
DXR
Daxor’s blood volume analysis validated for COVID, sepsis patients
Premium
The Fly
Daxor’s blood volume analysis validated for COVID, sepsis patients
8M ago
DXR
Daxor reports increase in NAV to $7.15 per share
PremiumThe Fly
Daxor reports increase in NAV to $7.15 per share
8M ago
DXR
Daxor’s FDA Clearance and Advancements Propel Buy Rating Amidst Growth Potential
PremiumRatings
Daxor’s FDA Clearance and Advancements Propel Buy Rating Amidst Growth Potential
9M ago
DXR
Why Is Daxor Stock (DXR) Up 20% Today?
PremiumMarket News
Why Is Daxor Stock (DXR) Up 20% Today?
9M ago
DXR
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories
PremiumMarket News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories
9M ago
TM
AMD
Daxor Gains FDA Clearance for Blood Volume Analyzer
PremiumCompany AnnouncementsDaxor Gains FDA Clearance for Blood Volume Analyzer
9M ago
8K
DXR
Daxor receives FDA clearance for new BVA system
Premium
The Fly
Daxor receives FDA clearance for new BVA system
9M ago
DXR
Daxor expands BVA technology into three new hospitals
Premium
The Fly
Daxor expands BVA technology into three new hospitals
10M ago
DXR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >